-
Most Popular
Search Results
240 results for mhp
Moody’s, McGraw-Hill Still Don’t Rate
If the Europe crisis really is resolved, both could enjoy a business rebound. However, Moody’s (MCO) still would be an expensive way to buy that…
8 Companies Boosting Dividends Last Week
These firms saw a good time to give back to shareholders.
16 Companies Increasing Dividends
Energy, publishing and retail companies are among the top payout performers for the past week.
Market Analysis – Correction Could be Around the Corner
If the market doesn’t make a better showing than it did yesterday, this pullback could turn into a genuine, full-fledged correction.
Market Analysis – Market in a Vulnerable Position
With yesterday’s failed rally and the news controlling the market, if you’re a bull you had better be looking for someone to pull a rabbit…
Pullback Ahead?
Most technicians are saying that the market is exhausted and due for a rest. Maybe, but don’t fall for the bull that it’s due for…
50 Blue-Chip Stocks Increasing Dividends in Q1 2013
What’s not to love about a big, blue-chip stock that has put its money where its shareholders are with even bigger payouts? These 50 companies…
Thursday Apple Rumors: They Only Want iPad
Hewlett-Packard shareholders should be nervous about Q2 earnings — the TouchPad can’t get out from underneath the shadow of the iPad.
Earnings Momentum Keeps MLP & Strategic Equity Fund (MTP) a Sell
Currently, MLP & Strategic Equity Fund (NASDAQ:MTP) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier’s investing methodology. MTP has maintained…
MLP & Strategic Equity Fund (MTP) a Sell on Flopping Earnings Visibility
MLP & Strategic Equity Fund (NASDAQ:MTP) is classified as a component of the 349 company Biotechnology GICS industry group, which is a segment of the…
Analytics for Industry Group Rank Keep MLP & Strategic Equity Fund (MTP) a Sell
MLP & Strategic Equity Fund (NASDAQ:MTP) is a $40.9 billion in market value component of the Biotechnology GICS industry group where the current Portfolio Grader…
MLP & Strategic Equity Fund (MTP) a Sell on Adverse Earnings Growth
The current recommendation of Sell for MLP & Strategic Equity Fund (NASDAQ:MTP) is the result of using the system for investing of Louis Navellier and…
Analytics for Quant Score Make MLP & Strategic Equity Fund (MTP) a Sell
The current recommendation of Sell for MLP & Strategic Equity Fund (NASDAQ:MTP) is computed using the methods for investing of Louis Navellier and his Portfolio…
MLP & Strategic Equity Fund (MTP) Sell Recommendation Retained
Portfolio Grader currently ranks MLP & Strategic Equity Fund (NASDAQ:MTP) a Sell. Using Louis Navellier’s investing methodology, this analytical tool researches stocks by employing proprietary…
Earnings Visibility Make MLP & Strategic Equity Fund (MTP) a Sell
Portfolio Grader currently ranks MLP & Strategic Equity Fund (NASDAQ:MTP) a Sell. The methods for fundamental and quantitative metrics used in this analytical tool, developed…
Earnings Visibility Keeps MLP & Strategic Equity Fund (MTP) a Sell
MLP & Strategic Equity Fund (NASDAQ:MTP) is a member of the 345 company Biotechnology GICS industry group, which is part of the 782 company GICS…
Adverse Earnings Growth Keep MLP & Strategic Equity Fund (MTP) a Sell
As one of the 785 companies in the GICS Health Care sector MLP & Strategic Equity Fund (NASDAQ:MTP) is a member of the 349 company…
MLP & Strategic Equity Fund (MTP) a Sell on Flagging Sales Growth
MLP & Strategic Equity Fund (NASDAQ:MTP) ranks in the top 10% of its industry group, Biotechnology, and in the top 10% of its sector group,…
Trade of the Day: Bull Run in MMP Stock Far From Over
I’m raising my price target for Magellan Midstream Partners, L.P.
3 – 10 of 240 results
